MTF Biologics and Kolosis introduced DBX Fiber, the latest addition to the DBX family. The companies expanded their partnership in 2025 to include distribution of the DBX family of allograft products.
DBX Fiber expands the DBX portfolio with a fiber tissue form processed to provide surgeons with superior handling and osteoinductive potential when addressing complex anatomy and challenging fusion environments.
The addition of DBX Fiber enhances Kolosis’ portfolio of surgical biologics, which already includes DBX Mix and DBX Putty, as well as technologies such as Kore Fiber 100% cortical bone allograft, and Summit Matrix, an advanced synthetic bone graft manufactured to support bone regeneration in orthopedic and spinal procedures.
MTF Biologics and Kolosis introduced DBX Fiber, the latest addition to the DBX family. The companies expanded their partnership in 2025 to include distribution of the DBX family of allograft products.
DBX Fiber expands the DBX portfolio with a fiber tissue form processed to provide surgeons with superior handling and osteoinductive...
MTF Biologics and Kolosis introduced DBX Fiber, the latest addition to the DBX family. The companies expanded their partnership in 2025 to include distribution of the DBX family of allograft products.
DBX Fiber expands the DBX portfolio with a fiber tissue form processed to provide surgeons with superior handling and osteoinductive potential when addressing complex anatomy and challenging fusion environments.
The addition of DBX Fiber enhances Kolosis’ portfolio of surgical biologics, which already includes DBX Mix and DBX Putty, as well as technologies such as Kore Fiber 100% cortical bone allograft, and Summit Matrix, an advanced synthetic bone graft manufactured to support bone regeneration in orthopedic and spinal procedures.
Copy to clipboard 
